Don Ware is chair of the firm’s Intellectual Property Department and past member of the firm’s Executive Committee. He is recognized by Chambers USA, The Best Lawyers in America, IAM Patent Litigation 250, PLC Which Lawyer? and Massachusetts SuperLawyers for his prominence in intellectual property. Don represents leading biopharma manufacturers, information technology companies, and universities in patent and inventorship disputes, technology transfer issues, and intellectual property strategy. He also advises clients on FDA matters, including the FDA’s regulatory pathway for approval of biosimilars.
Don’s patent litigation experience involves a wide range of technologies. In the field of life sciences, he has successfully litigated major cases involving recombinant DNA, monoclonal antibodies, siRNAs, small molecule compounds, drug delivery, molecular diagnostics, research tool patents, and medical devices. Don has also litigated patent disputes in a variety of other fields, ranging from Internet search engines to integrated circuits.
In addition to his trial practice, Don has extensive experience in appellate litigation, including appearances before the United States Supreme Court, the U.S. Court of Appeals for the Federal Circuit, and many other state and federal courts. He is also experienced in alternative dispute resolution, including mediation and arbitration, both as party counsel and as an arbitrator in the International Chamber of Commerce and the International Centre for Dispute Resolution.
Court Admissions
- U.S. District Court for the District of Massachusetts
- U.S. District Court for the Eastern District of Texas
- U.S. Court of Appeals Federal Circuit
- U.S. Court of Appeals First Circuit
- U.S. Court of Appeals Ninth Circuit
- Supreme Court of the United States
